November 14, 2019 Re: Clarification of the operating results of company and its subsidiaries for the nine month periods ended September 30, 2019 To: President The Stock Exchange of Thailand K.C
ที่ FPI Ref. FPI.008/2020 11 August 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 2 2020 To : Board of Directors and President of The Stock Exchange of Thailand
EKH/CS/2020/030 11 August 2020 Subject: Management Discussion and Analysis for the Second Quarter 2020 results To Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public
ที่ บช NO. AC.03/2020 14 August 2020 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M.K. Real Estate Development Plc
วันที่ 14 สิงหาคม 2550 DEMCO Public Company Limited No. Demco AC003/2020 August 14, 2020 Subject : The company’s operating result for the quarter 2/2020 To : The president, The Stock Exchange of
: Management explanation and analysis Quarter 3/2020 ending 30 September 2020 Attention: The President of, The Stock Exchange of Thailand Ziga Innovation Public Company Limited (“the Company”) manufactures and
ที่ บช NO. AC. 02/2020 14 May 2020 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M.K. Real Estate Development Plc
224.66 million due to redemption of debenture in January 2020 in the amount of THB 300 million • Trade and Other Current Receivables decreased by THB 159.65 million from those as at December 31, 2019 to
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries